Evidence map›Paper›PMID 24598365›Full record

ArticleAmerican journal of physiology. Cell physiology2014

Human erythrocytes transport dehydroascorbic acid and sugars using the same transporter complex.

Jay M Sage, Anthony Carruthers

Abstract read
In one paragraph

Article in American journal of physiology. Cell physiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Erythroid glucose transport in health and disease.Pflugers Archiv : European journal of physiology · 2020
    Review
  9. Review
  10. Glucose transporters in brain in health and disease.Pflugers Archiv : European journal of physiology · 2020
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Melatonin transport into mitochondria.Cellular and molecular life sciences : CMLS · 2017
    Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jay M SageDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts.
Anthony CarruthersDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, Massachusetts anthony.carruthers@umassmed.edu.
University of Massachusetts Chan Medical School · US

Funding

SUGAR TRANSPORTER OLIGOMERIC STRUCTURE AND FUNCTIONR01DK044888 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CARRUTHERS, ANTHONY · 1992 to 2016
$4.2M
METABOLIC CONTROL OF SUGAR TRANSPORTR01DK036081 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CARRUTHERS, ANTHONY · 1986 to 2012
$3.4M
Metabolic control of sugar transportR56DK036081 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CARRUTHERS, ANTHONY · 2007 to 2007
$266k
NIDDK NIH HHS DK-36081NIDDK NIH HHS DK-44888NIDDK NIH HHS R01 DK044888
6 · The paper itself

Abstract

GLUT1, the primary glucose transport protein in human erythrocytes [red blood cells (RBCs)], also transports oxidized vitamin C [dehydroascorbic acid (DHA)]. A recent study suggests that RBC GLUT1 transports DHA as its primary substrate and that only a subpopulation of GLUT1 transports sugars. This conclusion is based on measurements of cellular glucose and DHA equilibrium spaces, rather than steady-state transport rates. We have characterized RBC transport of DHA and 3-O-methylglucose (3-OMG), a transported, nonmetabolizable sugar. Steady-state 3-OMG and DHA uptake in the absence of intracellular substrate are characterized by similar Vmax (0.16 ± 0.01 and 0.13 ± 0.02 mmol·l(-1)·min(-1), respectively) and apparent Km (1.4 ± 0.2 and 1.6 ± 0.7 mM, respectively). 3-OMG and DHA compete for uptake, with Ki(app) of 0.7 ± 0.4 and 1.1 ± 0.1 mM, respectively. Uptake measurements using RBC inside-out-membrane vesicles demonstrate that 3-OMG and DHA compete at the cytoplasmic surface of the membrane, with Ki(app) of 0.7 ± 0.1 and 0.6 ± 0.1 mM, respectively. Intracellular 3-OMG stimulates unidirectional uptake of 3-OMG and DHA. These findings indicate that DHA and 3-OMG bind at mutually exclusive sites at exo- and endofacial surfaces of GLUT1 and are transported via the same GLUT1 complex.

Indexed as

3-O-MethylglucoseBinding, CompetitiveBinding SitesBiological TransportCarbon RadioisotopesDehydroascorbic AcidErythrocyte MembraneGlucoseGlucose Transporter Type 1HumansKineticsProtein BindingTritium3-O-MethylglucoseCarbon RadioisotopesDehydroascorbic AcidGlucoseGlucose Transporter Type 1SLC2A1 protein, humanTritiumdehydroascorbic acid transporterythrocyteglucose transportGLUT1

Identifiers

PMID24598365
PMCPMC4024712
OpenAlexW2320159924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.